The underlying letter count in phase 2 with RAP patients excluded was 4.4. With further tweaking of baseline characteristics in phase 3, this letter count should be regarded as the minimum target if the upcoming study replicates the efficacy of the previous. In addition, control outperformed by approximately .6 letters in phase 2.
- Forums
- ASX - By Stock
- OPT
- Ann: Security Class Reinstatement to Quotation- OPTOB
OPT
opthea limited
Add to My Watchlist
0.00%
!
60.0¢

Ann: Security Class Reinstatement to Quotation- OPTOB, page-572
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OPT (ASX) Chart |
Day chart unavailable
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online